Baxter International reported $2.3B in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Abbott USD 7.34B 22M Sep/2026
AngioDynamics USD 65.57M 3.56M Sep/2025
Artivion USD 107.05M 3.69M Sep/2026
AtriCure USD 87.31M 3.38M Sep/2026
Baxter International USD 2.3B 41M Sep/2026
Becton, Dickinson and Co. USD 3.19B 125M Sep/2026
Boston Scientific USD 3.32B 82M Sep/2026
Cooper Companies USD 896.4M 20M Mar/2026
Dexcom USD 770.7M 44.3M Sep/2026
Edwards Lifesciences USD 1.16B 28.2M Sep/2026
Fresenius EUR 2.77B 43M Jun/2026
Globus Medical USD 824.14M 13.25M Sep/2026
Halozyme Therapeutics USD 132.61M 4.52M Sep/2026
ICU Medical USD 607.27M 153K Sep/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 552.1M 67.3M Sep/2026
Integra LifeSciences USD 464.45M 27.55M Sep/2026
Intuitive Surgical USD 2.13B 99.5M Sep/2026
J&J USD 15.38B 233M Sep/2026
Laboratory Of America USD 538.4M 23.8M Sep/2026
Medtronic USD 6.22B 264M Jun/2026
Merit Medical Systems USD 391.02M 16.91M Sep/2026
Quest Diagnostics USD 218M 15M Sep/2026
Stryker USD 5.75B 226M Sep/2026
Tandem Diabetes Care USD 143.12M 8.01M Sep/2026
Teleflex USD 384.42M 32.5M Sep/2026
Terumo JPY 341.11B 5.48B Jun/2026
Zimmer Biomet Holdings USD 2.37B 96.9M Sep/2026